/
/
/

Bacil Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)24.53
Volume (₹)16,527.00
High (₹)24.53
Upper Circuit24.54
Low (₹)23.45
Lower Circuit22.22
Prev Close23.38
52W High (₹)61.80
Price24.00
52W Low (₹)10.65

Share Market Cap & Key Ratios Overview

M.Cap (₹)33.56 Cr
Div. Yield (%)0.00
PE Ratio51.00
Debt to Equity0.01
Price to Book2.28
Book Value18.60
EPS (TTM)0.46
Face Value10.00
ROE (%)3.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
BACPHAR-XTNSE
LTP
1W Low
1W High
Market cap (₹)
1865+29.5 (1.61%)
1835.50
1890.40
4,42,437Cr
9596.75+229.75 (2.45%)
9305.95
9621.25
2,48,054Cr
4980+175.75 (3.66%)
4864.80
4998.20
1,89,842Cr
1169.5+16.5 (1.43%)
1152
1178.05
1,15,810Cr
1380+8.55 (0.62%)
1364
1404.35
1,11,565Cr
2034.8+79.55 (4.07%)
1964.50
2037.45
1,08,338Cr
2462.5+144.5 (6.23%)
2302.30
2492.65
1,02,410Cr
1210.1+39 (3.33%)
1186.20
1221.60
1,01,163Cr
1725-10 (-0.58%)
1690
1739
97,642Cr
2100-44.7 (-2.08%)
2085
2129.85
96,950Cr
24+2.56 (11.94%)
20.37
24.53
34Cr

Key Highlights of Bacil Pharma Ltd Balance Sheet

Bacil Pharma Ltd balance sheet discloses shareholders' funds of ₹13.97Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹13.97Cr, and the reserves and surplus of the company is ₹11.46Cr.

The company has its non-current liabilities with total liabilities of ₹25.55Cr as of 2025-03-31.

The current liabilities are ₹16.89Lakh as of 2025-03-31. At the same time, current assets are ₹2.91Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹21.36Cr and tangible assets of 0, provided in the Bacil Pharma Ltd financial statements.